Celularity Inc. company information, Employees & Contact Information

Celularity Announces Filing of Form 10-Q Quarterly Reports GlobeNewswire

$41.6M Debt Retired: Biotech Celularity Clears Financial Hurdles with Q1-Q2 Filings, Keeps Nasdaq Listing Stock Titan

Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law GlobeNewswire

Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt Investing News Network

$41.6 Million Debt Eliminated: Celularity Restructures Balance Sheet with Strategic IP Sale and Exclusive License Back Stock Titan

Celularity Inc. Notified by Nasdaq of Non-Compliance with Quarterly Filing Requirements Nasdaq

Biotech Celularity Faces Nasdaq Compliance Challenge Over Two Missing Quarterly Reports Stock Titan

Celularity Receives Nasdaq Notice Regarding Form 10-Q GlobeNewswire

Celularity Inc. Faces Potential Delisting from Nasdaq Due to Fee and Filing Delinquencies Nasdaq

Florida's New Stem Cell Law: Celularity and Fountain Life Team Up to Revolutionize Patient Care Stock Titan

Celularity Partners with Genting Berhad to Launch Stem Cell Therapies in Asia Pacific with New Facility in Bali Quiver Quantitative

Celularity Inc. to Host Investor and Analyst Research & Development Day Investing News Network

Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies GlobeNewswire

Celularity Inc. Partners with Fountain Life to Provide Stem Cell Therapies Following New Florida Law Nasdaq

Celularity Gets 60 Days to Fix Nasdaq Compliance After Missing Q1 Filing Deadline Stock Titan

Celularity Announces Chief Financial Officer Transition GlobeNewswire

Celularity Given Until May 1 to Address Dual Nasdaq Compliance Issues or Face Delisting Stock Titan

Celularity Announces Sudden CFO Departure, Taps Internal Talent and External Advisory Firm Stock Titan

CMS Extends Medicare Coverage for Wound Care Products: Major Win for Skin Substitute Market Stock Titan

Celularity Announces $250M in Funding to Deliver Treatments for Cancer, Inflammatory and Degenerative Diseases, and Functional Regeneration PR Newswire

Imugene and Celularity Announce an Exclusive Strategic GlobeNewswire

Celularity Announces Sales of UltraMIST® Ultrasound Healing Therapy Asset to Sanuwave Health, Inc. PR Newswire

Celularity Acquires CariCord, Inc., Adds Important Biosourcing Assets, Strategic Relationship with the University of Colorado's ClinImmune Labs PR Newswire

An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study Wiley Online Library

Sorrento Contributes To The Formation Of Celularity, Inc. For Breakthrough Placental Therapeutic Platform In Consortium With Leading Pharmaceutical Companies PR Newswire

Celgene Spinout Celularity Raises $250 Million To Develop Placental Cells To Attack Cancer Forbes

Celularity Announces Dosing of First Patient in Phase I Study of Human Placental Hematopoietic Stem Cell-Derived Natural Killer Cells (CYNK-001) in Adults with Recurrent Glioblastoma Multiforme (GBM) BioSpace

The Placental Stem Cell Advantage Bioprocess Online

CELU Stock Price and Chart — NASDAQ:CELU TradingView

GX Acquisition Corp. Provides Information Regarding Extension of Deadline to Complete Celularity Business Combination Stock Titan

Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease The Manila Times

Celularity Announces Agreement with AD Ports Group for Exclusive Product Distribution in Various Territories in the GCC and Egypt PR Newswire UK

Trump Order Preserves Medicare Skin Treatment Access Until 2025, MASS Coalition Applauds Stock Titan